← Evidence map

ArticleCancers2025

Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center.

Kento Shionoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025

this papercites it

Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center. | OpenQuestion